Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 09, 2022

BUY
$72.36 - $113.1 $355,721 - $555,999
4,916 Added 24.83%
24,714 $1.81 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $394,362 - $616,395
-5,450 Reduced 21.59%
19,798 $1.46 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $335,720 - $439,092
3,850 Added 17.99%
25,248 $2.71 Million
Q1 2022

May 17, 2022

SELL
$94.19 - $124.49 $461,907 - $610,498
-4,904 Reduced 18.64%
21,398 $2.38 Million
Q4 2021

Feb 17, 2022

SELL
$119.57 - $139.07 $117,776 - $136,983
-985 Reduced 3.61%
26,302 $3.39 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $181,549 - $236,728
-1,663 Reduced 5.74%
27,287 $3.63 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $42,945 - $49,515
-428 Reduced 1.46%
28,950 $3.13 Million
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $8,729 - $10,773
-86 Reduced 0.29%
29,378 $3.09 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $709,197 - $870,062
-8,258 Reduced 21.89%
29,464 $3.07 Million
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $950,202 - $1.21 Million
-13,063 Reduced 25.72%
37,722 $3.32 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $858,741 - $1.41 Million
-17,883 Reduced 26.04%
50,785 $3.83 Million
Q1 2020

May 13, 2020

SELL
$36.95 - $62.95 $56,681 - $96,565
-1,534 Reduced 2.19%
68,668 $3.67 Million
Q4 2019

Feb 12, 2020

BUY
$47.06 - $56.64 $390,362 - $469,828
8,295 Added 13.4%
70,202 $3.95 Million
Q3 2019

Nov 13, 2019

SELL
$47.45 - $58.05 $199,574 - $244,158
-4,206 Reduced 6.36%
61,907 $2.95 Million
Q2 2019

Aug 08, 2019

BUY
$39.26 - $54.21 $2.6 Million - $3.58 Million
66,113 New
66,113 $3.58 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.